Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium

Tissue Engineering - Part C: Methods

Volumn 18, Issue 6, 2012, Pages 453-463

  Ginis, Irene ^a,b   Grinblat, Borislava ^a,c   Shirvan, Mitchell H ^a,b  

^a Teva Pharmaceutical Industries   (Israel)

^b Macrocure Ltd   (Israel)

^c Tel Hashomer Hospital   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BIOLOGICAL MATERIALS PRESERVATION; CELL CULTURE; CELL DEATH; DIMETHYL SULFOXIDE; ENZYME INHIBITION; FREEZING; LIQUID NITROGEN; ORGANIC SOLVENTS; PHOSPHATASES; RECOVERY; STEM CELLS; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE ACTIVITY; ANIMAL PRODUCTS; APOPTOTIC; APOPTOTIC CELLS; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; CASPASE-3; CELL THERAPY PRODUCTS; CELL VIABILITY; CLINICAL APPLICATION; CRYO-PRESERVATION; CRYOPRESERVED; FUNCTIONAL PARAMETERS; HUMAN BONES; HYPOTHERMIC; LIVE CELL; MEASURING CELLS; MESENCHYMAL STEM CELL; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC POTENTIAL; PROLIFERATION RATE; PROTECTIVE REAGENT; SURFACE EXPRESSION;

MOLECULAR BIOLOGY;

ANIMALIA;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CASPASE 3;

APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CALIBRATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COLD; CRYOPRESERVATION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; EVALUATION; FLOW CYTOMETRY; FREEZING; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; TIME;

ALKALINE PHOSPHATASE; APOPTOSIS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CALIBRATION; CASPASE 3; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COLD TEMPERATURE; CRYOPRESERVATION; CULTURE MEDIA; FLOW CYTOMETRY; FREEZING; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; TIME FACTORS;

EID: 84861795594     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2011.0395     Document Type: Article

References (37)

1. Gómez-Barrena, E., Rosset, P., Mü ller, I., Giordano, R., Bunu, C., Layrolle,P., Konttinen, Y.T., and Luyten, F.P. Bone regeneration: stem cell therapies and clinical studies in orthopedics and traumatology. J Cell Mol Med 15, 1266, 2011.
2. Guilak, F., Estes, B.T., Diekman, B.O., Moutos, F.T., and Gimble, J.M. 2010 Nicolas Andry Award: Multipotent adult stem cells from adipose tissue for musculoskeletal tissue engineering. Clin Orthop Relat Res 468, 2530, 2010.
3. El Tamer, M.K., and Reis, R.L. Progenitor and stem cells for bone and cartilage regeneration. J Tissue Eng Regen Med 3, 327, 2009.
4. Arthur, A., Zannettino, A., and Gronthos, S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 218, 237, 2009.
5. Vinatier, C., Bouffi, C., Merceron, C., Gordeladze, J., Brondello, J.M., Jorgensen, C., Weiss, P., Guicheux, J., and Noël, D. Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Curr Stem Cell Res Ther 4, 318, 2009.
6. Petrie Aronin, C.E, and Tuan, R.S. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today 90, 67, 2010.
7. Tasso, R., and Pennesi, G. When stem cells meet immunoregulation. Int Immunopharmacol 9, 596, 2009.
8. Meirelles Lda, S., Fontes, A.M., Covas, D.T., and Caplan, A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20, 419, 2009.
9. Hubel, A. Parameters of cell freezing: implications for the cryopreservation of stem cells. Transfus Med Rev 11, 224, 1997.
10. Snyder, K.K., Van Buskirk, R.G., Baust, J.M., Mathew, A.J., and Baust, J.G. Biological packaging for the global cell and tissue therapy markets. BioProcessing 3, 34, 2004.
11. Fong, C.Y., Subramanian, A., Biswas, A., Gauthaman, K., Srikanth, P., Hande, M.P., and Bongso, A. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online 21, 391, 2010.
12. Yalvaç, M.E., Ramazanoglu, M., Tekguc, M., Bayrak, O.F., Shafigullina, A.K., Salafutdinov, I.I., Blatt, N.L., Kiyasov, A.P., Sahin, F., Palotá s, A., and Rizvanov, A.A. Human tooth germ stem cells preserve neuro-protective effects after longterm cryo-preservation. Curr Neurovasc Res 7, 49, 2010.
13. Woods, E.J., Perry, B.C., Hockema, J.J., Larson, L., Zhou, D., and Goebel, W.S. Optimized cryopreservation method for human dental pulp-derived stem cells and their tissues of origin for banking and clinical use. Cryobiology 59, 150, 2009.
14. Gonda, K., Shigeura, T., Sato, T., Matsumoto, D., Suga, H., Inoue, K., Aoi, N., Kato, H., Sato, K., Murase, S., Koshima, I., and Yoshimura, K. Preserved proliferative capacity and multipotency of human adipose-derived stem cells after long-term cryopreservation. Plast Reconstr Surg 121, 401, 2008.
15. Haack-Sorensen, M., Bindslev, L., Mortensen, S., Friis, T., and Kastrup, J. The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use. Cytotherapy 9, 328, 2007.
16. Kotobuki, N., Hirose, M., Machida, H., Katou, Y., Muraki, K., Takakura, Y., and Ohgushi, H. Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng 11, 663, 2005.
17. Bruder, S., Jaiswal, N., and Haynesworth, S. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64, 278, 1997.
18. Liu, G., Shu, C., Cui, L., Liu, W., and Cao, Y. Tissue-engineered bone formation with cryopreserved human bone marrow mesenchymal stem cells. Cryobiology 56, 209, 2008.
19. Li, H., Yan, F., Lei, L., Li, Y., and Xiao, Y. Application of autologous cryopreserved bone marrow mesenchymal stem cells for periodontal regeneration in dogs. Cells Tissues Organs 190, 94, 2009.
20. Gao, D., and Critser, J.K. Mechanisms of cryoinjury in living cells. ILAR J 4, 187, 2000.
21. Zeisberger, S.M., Schulz, J.C., Mairhofer, M., Ponsaerts, P., Wouters, G., Doerr, D., Katsen-Globa, A., Ehrbar, M., Hescheler, J., Hoerstrup, S.P., Zisch, A.H., Kolbus A., and Zimmermann, H. Biological and physicochemical characterization of a serum-and xeno-free chemically defined cryopreservation procedure for adult human progenitor cells. Cell Transplant 20, 1241, 2011.
22. Halfon, S., Abramov, N., Grinblat, B., and Ginis, I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev 20, 53, 2011.
23. Ebertz, S.L., and McGann, L.E. Cryoinjury in endothelial cell monolayers. Cryobiology 49, 37, 2004.
24. Bertrand, R., Solary, E., O'Connor, P., Kohn, K.W., and Pommier, Y. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 211, 314, 1994.
25. Elstein, K.H., and Zucker, R.M. Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations. Exp Cell Res 211, 322, 1994.
26. Carvalho, K., Cury, C., Oliveira, L., Cattaned, R., Malvezzi, M., Francisco, J., Pachalok A., Olandoski M., Faria-Neto J.R., and Guarita-Souza, L.C. Evaluation of bone marrow mesenchymal stem cell standard cryopreservation procedure efficiency. Transplant Proc 40, 839, 2008.
27. Baust, J.M., Van Buskirk, R., and Baust, J.G. Gene activation of the apoptotic caspase cascade following cryogenic storage. Cell Preservation Technol 1, 63, 2002.
28. Baust, J.M., Van Buskirk, R.G, and Baust, J.G. Cell viability improves following inhibition of cryopreservation-induced apoptosis. In Vitr Cell Dev Biol Anim 36, 262, 2000.
29. Ding, G., Wang, W., Liu, Y., An, Y., Zhang, C., Shi, S., and Wang, S. Effect of cryopreservation on biological and immunological properties of stem cells from apical papilla. J Cell Physiol 223, 415, 2010.
30. Mathew, A.J., Baust, J.G., and Van Buskirk, R.G. Optimization of HypoThermosol-for the hypothermic storage of cardiomyocytes-addition of EDTA. In Vitr Toxicol 10, 407, 1997.
31. Dahdah, N.S., Taylor, M.J., Russo, P., and Wagerle, L.C. Effects of hypothermosol, an experimental acellular solution for tissue preservation and cardiopulmonary bypass, on isolated newborn lamb coronary vessels subjected to ultra profound hypothermia and anoxia. Cryobiology 39, 58, 1999.
32. Mathew, A.J., Van Buskirk, R.G., and Baust, J.G. Improved hypothermic preservation of human renal cells through suppression of both apoptosis and necrosis. Cell Preservation Technol 1, 239, 2002.
33. Mathew, A.J, Hollister, W., Addona, T., Baust, J.G, and Van Buskirk, R.G. Vitamin E and EDTA improve the efficacy of Hypothermosol-implication of apoptosis. In Vitr Mol Toxicol 12, 163, 1999.
34. Abrahamse, S.L., van Runnard, H.P., Hartman, R.J., Chamuleau, R.A., and van Gulik, T.M. Induction of necrosis and DNA fragmentation during hypothermic preservation of hepatocytes in UW, HTK, and Celsior solutions. Cell Transplant 12, 59, 2003.
35. Salahudeen, A.K., Huang, H., Joshi, M., Moore, N.A., and Jenkins, J.K. Involvement of the mitochondrial pathway in cold storage and rewarming-associated apoptosis of human renal proximal tubular cells. Am J Transplant 3, 273, 2003.
36. Ostrowska, A., Gu, K., Bode, D.C., and Van Buskirk, R.G. Hypothermic storage of isolated human hepatocytes: a comparison between University of Wisconsin solution and a hypothermosol platform. Arch Toxicol 83, 493, 2009.
37. Mathew, A.J., Baust, J.M., Van Buskirk, R.G., and Baust, J.G. Cell preservation in reparative and regenerative medicine: evolution of individualized solution composition. Tissue Eng 10, 1662, 2004.